Ser49Gly of β 1-adrenergic receptor is associated with effective β-blocker dose in dilated cardiomyopathy

Clinical Pharmacology and Therapeutics

Volumn 78, Issue 3, 2005, Pages 221-231

  Magnusson, Yvonne ^a   Levin, Malin C ^a   Eggertsen, Robert ^a   Nyström, Ernst ^a   Mobini, Reza ^a   Schaufelberger, Maria ^a   Andersson, Bert ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CARVEDILOL; METOPROLOL; DNA; GLYCINE; SERINE;

ADULT; AGED; ARTICLE; CODON; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART RATE; HETEROZYGOTE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME; AMINO ACID SUBSTITUTION; CLINICAL TRIAL; COHORT ANALYSIS; DOSE RESPONSE; DRUG EFFECT; GENETICS; MIDDLE AGED; MULTICENTER STUDY; PROSPECTIVE STUDY;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMINO ACID SUBSTITUTION; CARDIOMYOPATHY, DILATED; CODON; COHORT STUDIES; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENOTYPE; GLYCINE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROSPECTIVE STUDIES; RECEPTORS, ADRENERGIC, BETA-1; SERINE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 24344431994     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clpt.2005.06.004     Document Type: Article

References (31)

1. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II) a randomised trial [see comments] Lancet 353 1999 9 13
2. Effect of metoprolol CR/XL in chronic heart failure Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 1999 2001 2007
3. A. Maqbool, A.S. Hall, S.G. Ball, A.J. Balmforth Common polymorphisms of beta1-adrenoceptor identification and rapid screening assay [letter] Lancet 353 1999 897
4. F. Tesson, P. Charron, M. Peuchmaurd, V. Nicaud, F. Cambien, L. Tiret CARDIGENE Group Characterization of a unique genetic variant in the beta1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy J Mol Cell Cardiol 31 1999 1025 1032
5. H.L. White, A. Maqbool, A.D. McMahon, L. Yates, S.G. Ball, A.S. Hall An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy Eur Heart J 23 2002 1087 1092
6. L.E. Wagoner, L.L. Craft, P. Zengel, N. McGuire, D.A. Rathz, G.W. Dorn Polymorphisms of the beta1-adrenergic receptor predict exercise capacity in heart failure Am Heart J 144 2002 840 846
7. M. Borjesson, Y. Magnusson, A. Hjalmarson, B. Andersson A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure Eur Heart J 21 2000 1853 1858
8. M.C. Levin, S. Marullo, O. Muntaner, B. Andersson, Y. Magnusson The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation J Biol Chem 277 2002 30429 30435
9. D.A. Rathz, K.M. Brown, L.A. Kramer, S.B. Liggett Amino acid 49 polymorphisms of the human beta1-adrenergic receptor affect agonist-promoted trafficking J Cardiovasc Pharmacol 39 2002 155 160
10. M.R. Bristow beta-Adrenergic receptor blockade in chronic heart failure Circulation 101 2000 558 569
11. J. Mialet Perez, D.A. Rathz, N.N. Petrashevskaya, H.S. Hahn, L.E. Wagoner, A. Schwartz Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure Nat Med 9 2003 1300 1305
12. H.L. White, R.A. de Boer, A. Maqbool, D. Greenwood, D.J. van Veldhuisen, R. Cuthbert An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure a MERIT-HF sub-study Eur J Heart Fail 5 2003 463 468
13. G.G. Sofowora, V. Dishy, M. Muszkat, H.G. Xie, R.B. Kim, P.A. Harris A common beta1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to beta-blockade Clin Pharmacol Ther 73 2003 366 371
14. J.A. Johnson, I. Zineh, B.J. Puckett, S.P. McGorray, H.N. Yarandi, D.F. Pauly Beta 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol Clin Pharmacol Ther 74 2003 44 52
15. B. Andersson, K. Caidahl, F. Waagstein Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure Eur Heart J 16 1995 53 60
16. B. Andersson, K. Caidahl, F. Waagstein An echocardiographic evaluation of patients with idiopathic heart failure Chest 107 1995 680 689
17. R. Lewontin The interaction of selection and linkage. I. General considerations; heterotic models Genetics 49 1964 49 67
18. S. Podlowski, K. Wenzel, H.P. Luther, J. Muller, P. Bramlage, G. Baumann Beta1-adrenoceptor gene variations a role in idiopathic dilated cardiomyopathy? J Mol Med 78 2000 87 93
19. B. Lindelow, B. Andersson, F. Waagstein, C.H. Bergh Prognosis of alternative therapies in patients with heart failure not accepted for heart transplantation J Heart Lung Transplant 14 1995 1204 1211
20. K. Ranade, E. Jorgenson, W.H. Sheu, D. Pei, C.A. Hsiung, F.T. Chiang A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate Am J Hum Genet 70 2002 935 942
21. B. Andersson, J. Aberg, B. Lindelow, M.S. Tang, J. Wikstrand Dose-related effects of metoprolol on heart rate and pharmacokinetics in heart failure J Card Fail 7 2001 311 317
22. M.L. Kukin, J. Kalman, R.H. Charney, D.K. Levy, C. Buchholz-Varley, O.N. Ocampo Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure Circulation 99 1999 2645 2651
23. J. Liu, Z.Q. Liu, Z.R. Tan, X.P. Chen, L.S. Wang, G. Zhou Gly389Arg polymorphism of beta1-adrenergic receptor is associated with the cardiovascular response to metoprolol Clin Pharmacol Ther 74 2003 372 379
24. K.M. O'Shaughnessy, B. Fu, C. Dickerson, D. Thurston, M.J. Brown The gain-of-function G389R variant of the beta1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects Clin Sci (Lond) 99 2000 233 238
25. Y. Magnusson, M. Levin, E. Lindberg, B. Andersson The Ser49Gly polymorphism of the beta-1-adrenergic receptor determines sensitivity for intrinsic activity, in particular for the inverse agonism of metoprolol [abstract] Eur Heart J 24 2003 311
26. S.G. Terra, D.F. Pauly, C.R. Lee, J.H. Patterson, K.F. Adams, R.S. Schofield beta-Adrenergic receptor polymorphisms and responses during titration of metoprolol controlled release/extended release in heart failure Clin Pharmacol Ther 77 2005 127 137
27. J.D. Moore, D.A. Mason, S.A. Green, J. Hsu, S.B. Liggett Racial differences in the frequencies of cardiac beta(1)-adrenergic receptor polymorphisms analysis of c145A>G and c1165G>C Hum Mutat 14 1999 271
28. J. Wikstrand, A. Hjalmarson, F. Waagstein, B. Fagerberg, S. Goldstein, J. Kjekshus Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF) J Am Coll Cardiol 40 2002 491 498
29. C. Sachse, J. Brockmoller, S. Bauer, I. Roots Cytochrome P450 2D6 variants in a Caucasian population allele frequencies and phenotypic consequences Am J Hum Genet 60 1997 284 295
30. H. Wuttke, T. Rau, R. Heide, K. Bergmann, M. Bohm, J. Weil Increased frequency of cytochrome P450 2D6 poor metabolizers among patients with metoprolol-associated adverse effects Clin Pharmacol Ther 72 2002 429 437
31. B. Andersson, E. Kjörk, G. Brunlöf Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment Int J Cardiol. 2005 In press 2005. Available online March 2, 2005